Dr. Hilderson Ingeborg Oncologe
ActiveFrom the official registers: KBO 2 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
Dr. Hilderson Ingeborg Oncologe has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €107,765 and a net result of €81,657. The computed 12-month bankruptcy probability is 0.3% (very low).
Overview
Official details
KBO- Status
- Active since 16-10-2024 Normal situation
- Activity
- “De uitoefening van de beroepsactiviteit van geneesheer-specialist in de oncologie, met inachtneming van de…” (deed in Dutch)From the articlesNo NACE code in the KBO yet
- Establishment unit
- 2.365.404.584 9840 Nazareth-De Pinte, since 16-10-2024
- Financial year end
- 31 December
- Peppol
- Reachable since 14-07-2026
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.3%
- Gross margin
- €104,077
- ▲ 215%
- Turnover
- ≈ €260,000
- estimated
- Profit
- €81,657
- ▲ 215%
- Equity
- €107,765
- ▲ 300%
- Total assets
- €112,615
- ▲ 212%
Score breakdownraises riskFounded in 2024lowers riskLiquidity: current ratio 22.36, cash €27,751Size: total assets €112,615Equity €107,765 (95.7% of total assets)Show the evidence
Checked score
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 81% of them on solvency, 74% on liquidity, 90% on profitability and 97% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 2 accounts on average 15 days before the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
Key points
- Positive: Result rose in 2025from €25,941 to €81,657 ▲ 215% View
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 16-07-2026
- Annual accounts 2024filed on 16-07-2025
Acts in the Belgian Official Gazette
- Incorporationact of 18-10-2024
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about Dr. Hilderson Ingeborg Oncologe
- What is the company number of Dr. Hilderson Ingeborg Oncologe?
- The company number of Dr. Hilderson Ingeborg Oncologe is 1015.187.152. The VAT number is the same number with BE in front: BE 1015.187.152.
- Where is Dr. Hilderson Ingeborg Oncologe based?
- The registered office is at Oude Gentweg 96, 9840 Nazareth-De Pinte.Company details
- What is the legal form of Dr. Hilderson Ingeborg Oncologe?
- The legal form of Dr. Hilderson Ingeborg Oncologe is Private limited company (BV).
- When was Dr. Hilderson Ingeborg Oncologe founded?
- Dr. Hilderson Ingeborg Oncologe was founded on 16-10-2024.
- Is Dr. Hilderson Ingeborg Oncologe still active?
- Yes, Dr. Hilderson Ingeborg Oncologe is an active enterprise in the KBO register.
- What is the turnover of Dr. Hilderson Ingeborg Oncologe?
- The turnover in financial year 2025 is ≈ €260,000. This figure is estimated from the gross margin of €104,077 and 2,213 comparable companies of the same size. It probably lies between €170,000 and €400,000. It is a rough estimate.Financials
- Is Dr. Hilderson Ingeborg Oncologe profitable?
- In financial year 2025, Dr. Hilderson Ingeborg Oncologe made a profit of €81,657.
- Where can I find the annual accounts of Dr. Hilderson Ingeborg Oncologe?
- Dr. Hilderson Ingeborg Oncologe filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
- When are the next annual accounts of Dr. Hilderson Ingeborg Oncologe due?
- Dr. Hilderson Ingeborg Oncologe must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.